COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis
USA - NYSE:CHCT - US20369C1062 - REIT
15.68 USD
-0.05 (-0.32%)
15.68 USD
0 (0%)
Taking everything into account, CHCT scores 3 out of 10 in our fundamental rating. CHCT was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of CHCT have multiple concerns. While showing a medium growth rate, CHCT is valued expensive at the moment. CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT has reported negative net income.
In the past year CHCT had a positive cash flow from operations.
CHCT had positive earnings in 4 of the past 5 years.
CHCT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.08%, CHCT is doing worse than 68.22% of the companies in the same industry.
CHCT has a Return On Equity of -2.37%. This is in the lower half of the industry: CHCT underperforms 63.57% of its industry peers.
CHCT has a Return On Invested Capital (2.16%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for CHCT is in line with the industry average of 3.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.08% | ||
| ROE | -2.37% | ||
| ROIC | 2.16% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
1.3 Margins
CHCT has a Operating Margin of 22.02%. This is comparable to the rest of the industry: CHCT outperforms 50.39% of its industry peers.
In the last couple of years the Operating Margin of CHCT has declined.
The Gross Margin of CHCT (80.40%) is better than 81.40% of its industry peers.
In the last couple of years the Gross Margin of CHCT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.02% | ||
| PM (TTM) | N/A | ||
| GM | 80.4% |
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHCT is destroying value.
Compared to 1 year ago, CHCT has more shares outstanding
Compared to 5 years ago, CHCT has more shares outstanding
CHCT has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.82, we must say that CHCT is in the distress zone and has some risk of bankruptcy.
CHCT has a Altman-Z score of 0.82. This is in the better half of the industry: CHCT outperforms 68.22% of its industry peers.
The Debt to FCF ratio of CHCT is 41.17, which is on the high side as it means it would take CHCT, 41.17 years of fcf income to pay off all of its debts.
CHCT's Debt to FCF ratio of 41.17 is fine compared to the rest of the industry. CHCT outperforms 65.12% of its industry peers.
A Debt/Equity ratio of 1.15 is on the high side and indicates that CHCT has dependencies on debt financing.
CHCT has a Debt to Equity ratio (1.15) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 41.17 | ||
| Altman-Z | 0.82 |
ROIC/WACC0.31
WACC6.95%
2.3 Liquidity
CHCT has a Current Ratio of 0.59. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
CHCT has a Current ratio of 0.59. This is in the lower half of the industry: CHCT underperforms 75.19% of its industry peers.
CHCT has a Quick Ratio of 0.59. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
CHCT has a Quick ratio of 0.28. This is amonst the worse of the industry: CHCT underperforms 87.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.28 |
3. Growth
3.1 Past
CHCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -135.90%.
The earnings per share for CHCT have been decreasing by -10.22% on average. This is quite bad
Looking at the last year, CHCT shows a very negative growth in Revenue. The Revenue has decreased by -18.01% in the last year.
Measured over the past years, CHCT shows a quite strong growth in Revenue. The Revenue has been growing by 13.73% on average per year.
EPS 1Y (TTM)-135.9%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-1350%
Revenue 1Y (TTM)-18.01%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%9.49%
3.2 Future
The Earnings Per Share is expected to grow by 37.91% on average over the next years. This is a very strong growth
CHCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.17% yearly.
EPS Next Y-216.57%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
EPS Next 5YN/A
Revenue Next Year4.5%
Revenue Next 2Y5.28%
Revenue Next 3Y6.02%
Revenue Next 5Y9.17%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CHCT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 34.16, which means the current valuation is very expensive for CHCT.
Based on the Price/Forward Earnings ratio, CHCT is valued a bit cheaper than the industry average as 72.87% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.73. CHCT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 34.16 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHCT indicates a somewhat cheap valuation: CHCT is cheaper than 62.02% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CHCT is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.39 | ||
| EV/EBITDA | 13.56 |
4.3 Compensation for Growth
A more expensive valuation may be justified as CHCT's earnings are expected to grow with 37.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.84%
EPS Next 3Y37.91%
5. Dividend
5.1 Amount
CHCT has a Yearly Dividend Yield of 11.92%, which is a nice return.
Compared to an average industry Dividend Yield of 6.63, CHCT pays a better dividend. On top of this CHCT pays more dividend than 93.80% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, CHCT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.92% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.99%.
CHCT has been paying a dividend for at least 10 years, so it has a reliable track record.
As CHCT did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
CHCT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHCT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-508.87%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
15.68
-0.05 (-0.32%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners86.5%
Inst Owner Change-0.87%
Ins Owners5.63%
Ins Owner Change7.27%
Market Cap444.84M
Analysts81.82
Price Target19.48 (24.23%)
Short Float %3.5%
Short Ratio3.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.92% |
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-508.87%
Div Incr Years9
Div Non Decr Years9
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-73.26%
Min EPS beat(2)-88.54%
Max EPS beat(2)-57.98%
EPS beat(4)0
Avg EPS beat(4)-58.62%
Min EPS beat(4)-88.54%
Max EPS beat(4)-43.98%
EPS beat(8)0
Avg EPS beat(8)-52.43%
EPS beat(12)1
Avg EPS beat(12)-56.5%
EPS beat(16)1
Avg EPS beat(16)-45.99%
Revenue beat(2)0
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.52%
Revenue beat(4)0
Avg Revenue beat(4)-2.06%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.52%
Revenue beat(8)0
Avg Revenue beat(8)-3.6%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)2
Avg Revenue beat(16)-2.63%
PT rev (1m)-4.98%
PT rev (3m)-6.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20%
EPS NY rev (1m)-340%
EPS NY rev (3m)-340%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-3.87%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-0.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 34.16 | ||
| P/S | 3.77 | ||
| P/FCF | 36.39 | ||
| P/OCF | 7.71 | ||
| P/B | 1.02 | ||
| P/tB | 1.02 | ||
| EV/EBITDA | 13.56 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.46
Fwd EY2.93%
FCF(TTM)0.43
FCFY2.75%
OCF(TTM)2.03
OCFY12.97%
SpS4.16
BVpS15.43
TBVpS15.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.08% | ||
| ROE | -2.37% | ||
| ROCE | 2.74% | ||
| ROIC | 2.16% | ||
| ROICexc | 2.18% | ||
| ROICexgc | 2.21% | ||
| OM | 22.02% | ||
| PM (TTM) | N/A | ||
| GM | 80.4% | ||
| FCFM | 10.35% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexcg growth 3Y-9.66%
ROICexcg growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 41.17 | ||
| Debt/EBITDA | 7.24 | ||
| Cap/Depr | 104.47% | ||
| Cap/Sales | 38.52% | ||
| Interest Coverage | 1.05 | ||
| Cash Conversion | 82.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.59 | ||
| Quick Ratio | 0.28 | ||
| Altman-Z | 0.82 |
F-Score3
WACC6.95%
ROIC/WACC0.31
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.9%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-1350%
EPS Next Y-216.57%
EPS Next 2Y47.84%
EPS Next 3Y37.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.01%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%9.49%
Revenue Next Year4.5%
Revenue Next 2Y5.28%
Revenue Next 3Y6.02%
Revenue Next 5Y9.17%
EBIT growth 1Y-37.86%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year263.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y119.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.01%
OCF growth 3Y1.48%
OCF growth 5Y12.72%